Inventor · disambiguated record
John Mayo
Also filed as: MAYO JOHN · MAYO JOHN CHARLES
3 granted patents·8 pending applications·8 citations·filing 2010–2024
59Inventor score
Files withCANTAB BIOPHARMACEUTICALS PATENTS LTD5SEQUESSOME TECHNOLOGY HOLDINGS LTD2MAYO JOHN CHARLES1SCHLUMBERGER TECHNOLOGY CORP1SEQUESSOME TECH HOLDINGS LTD1
Top patents by PatentIndex Score
11 records- 0181US9555051B2Vesicular formulationsSEQUESSOME TECH HOLDINGS LTD·Filed 2013·Granted Jan 31, 2017·6 cites·10 claims
- 0270US10030471B2Well treatmentSCHLUMBERGER TECHNOLOGY CORP·Filed 2015·Granted Jul 24, 2018·2 cites·18 claims
- 0367US2025170244A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2024·Application pending·0 cites
- 0450US2021093721A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2020·Application pending·0 cites
- 0549US11351112B2Optimised subcutaneous therapeutic agentsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2017·Granted Jun 7, 2022·0 cites·5 claims
- 0645US2015132349A1Vesicular Formulations, Kits and UsesSEQUESSOME TECHNOLOGY HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 0745US2015125407A1Vesicular Formulations, Uses and MethodsSEQUESSOME TECHNOLOGY HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 0837US2015086524A1Optimised subcutaneous therapeutic agentsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2013·Application pending·0 cites
- 0937US2019192664A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2016·Application pending·0 cites
- 1034US2012220669A1Formulations for the treatment of deep tissue painMAYO JOHN CHARLES·Filed 2010·Application pending·0 cites
- 1131US2016175448A1Formulations for the Treatment of Deep Tissue PainTARGETED DELIVERY TECHNOLOGIES LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Mayo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →